Marinus Pharmaceuticals (MRNS) PT Raised to $3 at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Wall St futures rise as Fed rate hike lifts long-standing overhang
- Oil slips as Saudi Arabia offers more crude via Oman
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Exclusive-SK Hynix in talks with Intel about deal to make memory chips in US for the first time, sources say
- Trade the FOMC: How stocks tend to perform on Fed hike days
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Bernstein on Crypto: 'Clarity fails - what next?'
Marinus Pharma (MRNS) Reports Q2 Loss of $0.46
August 9, 2016 4:25 PM EDTMarinus Pharma (NASDAQ: MRNS) reported Q2 EPS of ($0.46), versus ($0.37) reported last year.
For earnings history and earnings-related data on Marinus Pharma (MRNS) click here.
... More
